Maurizio Vecchione is the executive vice president of the Global Good & Research group at Intellectual Ventures, where he oversees the integrated efforts of the Global Good Fund, the Intellectual Ventures Laboratory, and the Institute for Disease Modelling.
With more than 30 years of industry experience in technology and life sciences, he has helped build nine start-ups and launch more than 50 commercial products spanning health technologies and therapeutics as well as telecommunications, information systems, and material sciences. He most recently served as CEO of Arrogene, commercialising a nanotechnology platform for cancer therapeutics and diagnostics, and was CEO of telemedicine pioneer CompuMed.
He is an editorial advisory board member for IEEE Spectrum magazine. He’s also a member of the Board of Advisors for the Ronald Reagan UCLA Medical Center and the Leadership Council for UW Medicine/UW School of Public Health Department of Global Health. Additionally, he serves on the Board of Trustees of the Italian Scientists and Scholars of North America Foundation, which promotes collaboration between North American researchers and Italian academic and government institutions.
As an inventor himself, Maurizio is named on multiple US patents and patent applications related to imaging, image-processing, nano-bio-polymers, and telecommunications.
Osvald Bjelland, founder of The Performance Theatre said, “I am pleased to welcome Maurizio, a technology pioneer and inventor, to The Performance Theatre advisory board. His insights are invaluable as we focus on continuing to make impact and establish proof points that future-fit growth is within reach. I look forward to working with him.”
Maurizio Vecchione said, “In times like these, creating a safe space for leaders to engage differently with the world’s most challenging problems is no easy feat. I am delighted to join The Performance Theatre advisory board and I look forward to contributing to the development of this unique community.”
Rick Haythornthwaite, the advisory board’s chairman, added, “As The Performance Theatre continues to evolve, addressing the challenges of our time, the role of technology will be key in shaping our discussions. With his decades of experience in using technology to positively impact human life, I am sure we will benefit from Maurizio’s valuable perspectives.”